Long-term motor improvement after stroke is enhanced by short-term treatment with the alpha-2 antagonist, atipamezole

Brain Research

Volumn 1346, Issue , 2010, Pages 174-182

  Beltran, Erik J ^a,d   Papadopoulos, Catherine M ^a,d   Tsai, Shih Yen ^a   Kartje, Gwendolyn L ^a,b,c   Wolf, William A ^a,d  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b HINES VA HOSPITAL   (United States)

^c LOYOLA UNIVERSITY CHICAGO   (United States)

^d UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Middle cerebral artery occlusion; Norepinephrine; Physical therapy; Rat

Indexed keywords

ATIPAMEZOLE; SODIUM CHLORIDE; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; IMIDAZOLE DERIVATIVE;

ADRENERGIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; BRAIN DAMAGE; BRAIN ISCHEMIA; CONTROLLED STUDY; FORELIMB; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOTOR PERFORMANCE; NONHUMAN; PHYSIOTHERAPY; PRIORITY JOURNAL; RAT; SHORT COURSE THERAPY; STROKE; TREATMENT DURATION; WALKING; ANIMAL; CEREBRAL ARTERY DISEASE; CONVALESCENCE; DRUG EFFECTS; INSTRUMENTAL CONDITIONING; LONG EVANS RAT; MIDDLE CEREBRAL ARTERY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY; PSYCHOMOTOR PERFORMANCE;

ADRENERGIC ALPHA-AGONISTS; ANIMALS; CONDITIONING, OPERANT; FORELIMB; IMIDAZOLES; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MIDDLE CEREBRAL ARTERY; MOTOR SKILLS; PSYCHOMOTOR PERFORMANCE; RATS; RATS, LONG-EVANS; RECEPTORS, ADRENERGIC, ALPHA-2; RECOVERY OF FUNCTION; STROKE; ADRENERGIC ALPHA-2 RECEPTOR AGONISTS;

ANIMALIA; RATTUS;

EID: 77955516384     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2010.05.063     Document Type: Article

References (70)

1. D.L. Adkins, and T.A. Jones d-Amphetamine enhances skilled reaching after ischemic cortical lesions in rats Neurosci. Lett. 380 2005 214 218
2. A. Bachis, A. Mallei, M.I. Cruz, A. Wellstein, and I. Mocchetti Chronic antidepressant treatments increase basic fibroblast growth factor and fibroblast growth factor-binding protein in neurons Neuropharmacology 55 2008 1114 1120
3. A. Baird Potential mechanisms regulating the extracellular activities of basic fibroblast growth factor (FGF-2) Mol. Reprod. Dev. 39 1994 43 48
4. H.I. Berends, J.M. Nijlant, K.L. Movig, M.J. Van Putten, M.J. Jannink, and M.J. Ijzerman The clinical use of drugs influencing neurotransmitters in the brain to promote motor recovery after stroke; a Cochrane systematic review Eur. J. Phys. Rehabil. Med. 45 2009 621 630
5. M.G. Boyeson, and D.M. Feeney Intraventricular norepinephrine facilitates motor recovery following sensorimotor cortex injury Pharmacol. Biochem. Behav. 35 1990 497 501
6. M.G. Boyeson, T.R. Callister, and J.E. Cavazos Biochemical and behavioral effects of a sensorimotor cortex injury in rats pretreated with the noradrenergic neurotoxin DSP-4 Behav. Neurosci. 106 1992 964 973
7. S.D. Bury, and T.A. Jones Unilateral sensorimotor cortex lesions in adult rats facilitate motor skill learning with the "unaffected" forelimb and training-induced dendritic structural plasticity in the motor cortex J. Neurosci. 22 2002 8597 8606
8. S. Butovas, J. Lukkarinen, T. Virtanen, J. Jolkkonen, and J. Sivenius Differential effect of the alpha2-adrenoceptor antagonist, atipamezole, in limb-placing task and skilled forepaw use following experimental stroke Restor. Neurol. Neurosci. 18 2001 143 151
9. G. Chadi, B. Tinner, L.F. Agnati, and K. Fuxe Basic fibroblast growth factor (BFGF, FGF-2) immunoreactivity exists in the noradrenaline, adrenaline and 5-HT nerve cells of the rat brain Neurosci. Lett. 160 1993 171 176
10. M.J. Chen, T.V. Nguyen, C.J. Pike, and A.A. Russo-Neustadt Norepinephrine induces BDNF and activates the PI-3K and MAPK cascades in embryonic hippocampal neurons Cell. Signal. 19 2007 114 128
11. E.A. Crisostomo, P.W. Duncan, M. Propst, D.V. Dawson, and J.N. Davis Evidence that amphetamine with physical therapy promotes recovery of motor function in stroke patients Ann. Neurol. 23 1988 94 97
12. D.M. Feeney, and D.A. Hovda Amphetamine and apomorphine restore tactile placing after motor cortex injury in the cat Psychopharmacology (Berl) 79 1983 67 71
13. D.M. Feeney, and V.S. Westerberg Norepinephrine and brain damage: alpha noradrenergic pharmacology alters functional recovery after cortical trauma Can. J. Psychol. 44 1990 233 252
14. D.M. Feeney, A. Gonzales, and W.A. Law Amphetamine restores locomotor function after motor cortex injury in the rat Proc. West. Pharmacol. Soc. 24 1981 15 17
15. D.M. Feeney, A. Gonzalez, and W.A. Law Amphetamine, haloperidol, and experience interact to affect rate of recovery after motor cortex injury Science 217 1982 855 857
16. D.M. Feeney, A.M. De Smet, and S. Rai Noradrenergic modulation of hemiplegia: facilitation and maintenance of recovery Restor. Neurol. Neurosci. 22 2004 175 190
17. C. Flores, D. Rodaros, and J. Stewart Long-lasting induction of astrocytic basic fibroblast growth factor by repeated injections of amphetamine: blockade by concurrent treatment with a glutamate antagonist J. Neurosci. 18 1998 9547 9555
18. D.J. Foster, D.C. Good, A. Fowlkes, and L. Sawaki Atomoxetine enhances a short-term model of plasticity in humans Arch. Phys. Med. Rehabil. 87 2006 216 221
19. C. Garcia, M.J. Chen, A.A. Garza, C.W. Cotman, and A. Russo-Neustadt The influence of specific noradrenergic and serotonergic lesions on the expression of hippocampal brain-derived neurotrophic factor transcripts following voluntary physical activity Neuroscience 119 2003 721 732
20. S.M. Geranton, D.J. Heal, and S.C. Stanford Differences in the mechanisms that increase noradrenaline efflux after administration of d-amphetamine: a dual-probe microdialysis study in rat frontal cortex and hypothalamus Br. J. Pharmacol. 139 2003 1441 1448
21. G. Gilmour, S.D. Iversen, M.F. O'Neill, M.J. O'Neill, M.A. Ward, and D.M. Bannerman Amphetamine promotes task-dependent recovery following focal cortical ischaemic lesions in the rat Behav. Brain Res. 165 2005 98 109
22. A. Gobert, R. Billiras, L. Cistarelli, and M.J. Millan Quantification and pharmacological characterization of dialysate levels of noradrenaline in the striatum of freely-moving rats: release from adrenergic terminals and modulation by alpha2-autoreceptors J. Neurosci. Meth. 140 2004 141 152
23. L.B. Goldstein Neurotransmitters and motor activity: effects on functional recovery after brain injury NeuroRx 3 2006 451 457
24. L.B. Goldstein Amphetamine trials and tribulations Stroke 40 2009 S133 S135
25. L.B. Goldstein, and S. Bullman Differential effects of haloperidol and clozapine on motor recovery after sensorimotor cortex injury in rats Neurorehabil. Neural Repair 16 2002 321 325
26. C. Grade, B. Redford, J. Chrostowski, L. Toussaint, and B. Blackwell Methylphenidate in early poststroke recovery: a double-blind, placebo-controlled study Arch. Phys. Med. Rehabil. 79 1998 1047 1050
27. A. Haapalinna, T. Viitamaa, E. MacDonald, J.M. Savola, L. Tuomisto, R. Virtanen, and E. Heinonen Evaluation of the effects of a specific alpha 2-adrenoceptor antagonist, atipamezole, on alpha 1- and alpha 2-adrenoceptor subtype binding, brain neurochemistry and behaviour in comparison with yohimbine Naunyn Schmiedebergs Arch Pharmacol 356 1997 570 582
28. L. Hertz, Y. Chen, M.E. Gibbs, P. Zang, and L. Peng Astrocytic adrenoceptors: a major drug target in neurological and psychiatric disorders? Curr. Drug Targets CNS Neurol. Disord. 3 2004 239 267
29. D.A. Hovda, and D.M. Fenney Amphetamine with experience promotes recovery of locomotor function after unilateral frontal cortex injury in the cat Brain Res. 298 1984 358 361
30. J. Jolkkonen, K. Puurunen, S. Rantakomi, A. Harkonen, A. Haapalinna, and J. Sivenius Behavioral effects of the alpha(2)-adrenoceptor antagonist, atipamezole, after focal cerebral ischemia in rats Eur. J. Pharmacol. 400 2000 211 219 (Pubitemid 30438729)
31. T.A. Jones, C.J. Chu, L.A. Grande, and A.D. Gregory Motor skills training enhances lesion-induced structural plasticity in the motor cortex of adult rats J. Neurosci. 19 1999 10153 10163
32. V. Junker, A. Becker, R. Huhne, M. Zembatov, A. Ravati, C. Culmsee, and J. Krieglstein Stimulation of beta-adrenoceptors activates astrocytes and provides neuroprotection Eur. J. Pharmacol. 446 2002 25 36
33. D.M. Juric, D. Loncar, and M. Carman-Krzan Noradrenergic stimulation of BDNF synthesis in astrocytes: mediation via alpha1- and beta1/beta2-adrenergic receptors Neurochem. Int. 52 2008 297 306
34. M. Kajs-Wyllie Ritalin revisited: does it really help in neurological injury? J. Neurosci. Nurs. 34 2002 303 313
35. H. Karhunen, T. Virtanen, T. Schallert, J. Sivenius, and J. Jolkkonen Forelimb use after focal cerebral ischemia in rats treated with an alpha 2-adrenoceptor antagonist Pharmacol. Biochem. Behav. 74 2003 663 669
36. T. Kawamata, W.D. Dietrich, T. Schallert, J.E. Gotts, R.R. Cocke, L.I. Benowitz, and S.P. Finklestein Intracisternal basic fibroblast growth factor enhances functional recovery and up-regulates the expression of a molecular marker of neuronal sprouting following focal cerebral infarction Proc. Natl. Acad. Sci. U. S. A. 94 1997 8179 8184
37. T. Kawamata, E.K. Speliotes, and S.P. Finklestein The role of polypeptide growth factors in recovery from stroke Adv. Neurol. 73 1997 377 382
38. Y. Kawamoto, S. Nakamura, T. Kawamata, I. Akiguchi, and J. Kimura Cellular localization of brain-derived neurotrophic factor-like immunoreactivity in adult monkey brain Brain Res. 821 1999 341 349
39. H.K. Kimelberg Receptors on astrocytes-what possible functions? Neurochem. Int. 26 1995 27 40
40. A.E. Kline, M.J. Chen, D.Y. Tso-Olivas, and D.M. Feeney Methylphenidate treatment following ablation-induced hemiplegia in rat: experience during drug action alters effects on recovery of function Pharmacol. Biochem. Behav. 48 1994 773 779
41. J.H. Kwon, D.M. Vogt Weisenhorn, M. Downen, K. Ruan, L. Roback, H. Joshi, and B.H. Wainer Beta-adrenergic and fibroblast growth factor receptors induce neuronal process outgrowth through different mechanisms Eur. J. Neurosci. 10 1998 2776 2789
42. D. Laifenfeld, E. Klein, and D. Ben Shachar Norepinephrine alters the expression of genes involved in neuronal sprouting and differentiation: relevance for major depression and antidepressant mechanisms J. Neurochem. 83 2002 1054 1064
43. D. Laifenfeld, R. Karry, E. Grauer, E. Klein, and D. Ben Shachar Antidepressants and prolonged stress in rats modulate CAM-L1, laminin, and PCREB, implicated in neuronal plasticity Neurobiol. Dis. 20 2005 432 441
44. P. Langhorne, F. Coupar, and A. Pollock Motor recovery after stroke: a systematic review Lancet Neurol 8 2009 741 754
45. J. Liepert Pharmacotherapy in restorative neurology Curr. Opin. Neurol. 21 2008 639 643
46. C. Mannari, N. Origlia, A. Scatena, A. Del Debbio, M. Catena, G. Dell'agnello, A. Barraco, L. Giovannini, L. Dell'osso, L. Domenici, and A. Piccinni BDNF level in the rat prefrontal cortex increases following chronic but not acute treatment with duloxetine, a dual acting inhibitor of noradrenaline and serotonin re-uptake Cell. Mol. Neurobiol. 28 2008 457 468
47. L. Martinsson, H. Hardemark, and S. Eksborg Amphetamines for improving recovery after stroke Cochrane Database Syst. Rev. 1 2007 CD002090
48. G.A. Metz, and I.Q. Whishaw Cortical and subcortical lesions impair skilled walking in the ladder rung walking test: a new task to evaluate fore- and hindlimb stepping, placing, and co-ordination J. Neurosci. Meth. 115 2002 169 179
49. E.J. Nestler Molecular basis of long-term plasticity underlying addiction Nat. Rev. Neurosci. 2 2001 119 128
50. A. Newman-Tancredi, J.P. Nicolas, V. Audinot, S. Gavaudan, L. Verriele, M. Touzard, C. Chaput, N. Richard, and M.J. Millan Actions of alpha2 adrenoceptor ligands at alpha2A and 5-HT1A receptors: the antagonist, atipamezole, and the agonist, dexmedetomidine, are highly selective for alpha2A adrenoceptors Naunyn Schmiedebergs Arch Pharmacol 358 1998 197 206
51. C.M. Papadopoulos, S.Y. Tsai, V. Guillen, J. Ortega, G.L. Kartje, and W.A. Wolf Motor recovery and axonal plasticity with short-term amphetamine after stroke Stroke 40 2009 294 302
52. Y.H. Park, L. Kantor, K.K. Wang, and M.E. Gnegy Repeated, intermittent treatment with amphetamine induces neurite outgrowth in rat pheochromocytoma cells (PC12 cells) Brain Res. 951 2002 43 52
53. M.N. Patel, and J.O. McNamara Selective enhancement of axonal branching of cultured dentate gyrus neurons by neurotrophic factors Neuroscience 69 1995 763 770
54. A. Pertovaara, A. Haapalinna, J. Sirvio, and R. Virtanen Pharmacological properties, central nervous system effects, and potential therapeutic applications of atipamezole, a selective alpha2-adrenoceptor antagonist CNS Drug Rev. 11 2005 273 288
55. C. Plewnia, J. Hoppe, L.G. Cohen, and C. Gerloff Improved motor skill acquisition after selective stimulation of central norepinephrine Neurology 62 2004 2124 2126
56. K. Puurunen, J. Jolkkonen, J. Sirvio, A. Haapalinna, and J. Sivenius An alpha(2)-adrenergic antagonist, atipamezole, facilitates behavioral recovery after focal cerebral ischemia in rats Neuropharmacology 40 2001 597 606
57. M. Ramic, A.J. Emerick, M.R. Bollnow, T.E. O'Brien, S.Y. Tsai, and G.L. Kartje Axonal plasticity is associated with motor recovery following amphetamine treatment combined with rehabilitation after brain injury in the adult rat Brain Res. 1111 2006 176 186
58. J.F. Reilly, and V.G. Kumari Alterations in fibroblast growth factor receptor expression following brain injury Exp. Neurol. 140 1996 139 150
59. M.A. Riva, R. Molteni, and G. Racagni Differential regulation of FGF-2 and FGFR-1 in rat cortical astrocytes by dexamethasone and isoproterenol Brain Res. Mol. Brain Res. 57 1998 38 45
60. P. Rizk, J. Salazar, R. Raisman-Vozari, M. Marien, M. Ruberg, F. Colpaert, and T. Debeir The alpha2-adrenoceptor antagonist dexefaroxan enhances hippocampal neurogenesis by increasing the survival and differentiation of new granule cells Neuropsychopharmacology 31 2006 1146 1157
61. T.E. Robinson, and B. Kolb Alterations in the morphology of dendrites and dendritic spines in the nucleus accumbens and prefrontal cortex following repeated treatment with amphetamine or cocaine Eur. J. Neurosci. 11 1999 1598 1604
62. S. Rowntree, and B. Kolb Blockade of basic fibroblast growth factor retards recovery from motor cortex injury in rats Eur. J. Neurosci. 9 1997 2432 2441 (Pubitemid 28005995)
63. T. Schallert, S.M. Fleming, J.L. Leasure, J.L. Tillerson, and S.T. Bland CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, Parkinsonism and spinal cord injury Neuropharmacology 39 2000 777 787
64. H. Scheinin, E. MacDonald, and M. Scheinin Behavioural and neurochemical effects of antipamezole, a novel alpha 2-adrenoceptor antagonist Eur. J. Pharmacol. 151 1988 35 42
65. M.E. Schmidt, R.C. Risinger, R.L. Hauger, J.L. Schouten, M. Henry, and W.Z. Potter Responses to alpha 2-adrenoceptor blockade by idazoxan in healthy male and female volunteers Psychoneuroendocrinology 22 1997 177 188
66. H.D. Schmidt, M. Banasr, and R.S. Duman Future antidepressant targets: neurotrophic factors and related signaling cascades Drug Discov Today Ther Strateg 5 2008 151 156
67. K. Takami, Y. Kiyota, M. Iwane, M. Miyamoto, R. Tsukuda, K. Igarashi, A. Shino, A. Wanaka, S. Shiosaka, and M. Tohyama Upregulation of fibroblast growth factor-receptor messenger RNA expression in rat brain following transient forebrain ischemia Exp. Brain Res. 97 1993 185 194
68. O.Y. Wei, Y.L. Huang, C.D. Da, and J.S. Cheng Alteration of basic fibroblast growth factor expression in rat during cerebral ischemia Acta Pharmacol. Sin. 21 2000 296 300
69. I.Q. Whishaw Loss of the innate cortical engram for action patterns used in skilled reaching and the development of behavioral compensation following motor cortex lesions in the rat Neuropharmacology 39 2000 788 805
70. S. Zittel, C. Weiller, and J. Liepert Reboxetine Improves Motor Function in Chronic Stroke A Pilot Study. J Neurol 254 2007 197 201